Skip to main content

Table 1 Results of univariate analysis to determine factors associated with smoking status

From: Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery

  

Current smokers

Ex-smokers

<6 weeks

Ex-smokers

≥6 weeks

Never smokers

p-value

  

(n = 111)

(n = 55)

(n = 245)

(n = 51)

 

Mean (95%CI) age (years)

67 (65–68.3)f

68 (65.6–9.9)e,f

70 (68.8–70.8)e

72 (67.2–72.8)e,f

0.006a

Median (IQR) BMI (kg/m2)

24.1 (6.3)f

24 (7.5)e

26.9 (5.4)e,f

26 (6.4)e,f

<0.001b

Mean (95%CI) FEV1% predicted

72 (68.6–75.7)g

78 (73.5–81.8)f,g

79 (76.6–81.8)e,f

94 (87.4–100.5)e

<0.001a

COPD

50.4% (n = 56)g

20.0% (n = 11)f,g

26.9% (n = 66)e,f

5.9% (n = 3)e

<0.001c

COPD Severity (FEV1% predicted)

Mild (≥80)

18.9% (n = 21)

3.6% (n = 2)

6.5% (n = 16)

2% (n = 1)

0.358d

Moderate (≥50 to <80)

23.4% (n = 26)

16.4% (n = 9)

15.5% (n = 38)

3.9% (n = 2)

Severe (≥30 to <50)

8.1% (n = 9)

0%

4.5% (n = 11)

0%

Male sex

63.9% (n = 71)f

60.0% (n = 33)e,f

63.2% (n = 155)f

35.2% (n = 18)e

0.002c

Ischaemic heart disease

14.4% (n = 16)

18.1% (n = 10)

15.1% (n = 37)

7.8% (n = 4)

0.476c

Diabetes

12.6% (n = 14)

5.5% (n = 3)

13.1% (n = 32)

11.7% (n = 6)

0.503d

Hypertension

42.3% (n = 47)

41.8% (n = 23)

45.3% (n = 111)

52.9% (n = 27)

0.604c

ASA score ≥3

58.5% (n = 65)

52.7% (n = 29)

49.8% (n = 122)

41.2% (n = 21)

0.195c

Preoperative activity level <400 m

29.4% (n = 32/109)

25% (n = 13/52)

29.7% (n = 71/239)

21.6% (n = 11/51)

0.634c

Staging

I

54.1% (n = 60)

47.3% (n = 26)

48.2% (n = 118)

49.0% (n = 25)

0.36 d

II

29.7% (n = 33)

32.7% (n = 18)

34.7% (n = 85)

21.6% (n = 11)

IIIA

14.4% (n = 16)

18.2% (n = 10)

15.9% (n = 39

21.6% (n = 11)

IIIB

0.90% (n = 1)

0%

0.41% (n = 1)

3.9% (n = 2)

VATS

No

91.9% (n = 102)

85.5% (n = 47)

92.7% (n = 227)

92.2% (n = 47)

0.396d

Yes

8.1% (n = 9)

14.5% (n = 8)

7.3% (n = 18)

7.8% (n = 4)

Surgery

Lobectomy

81.1% (n = 90)

78.2% (n = 43)

77.6% (n = 190)

74.5% (n = 38)

0.592d

Subsegmectomy/wedge

10.8% (n = 12)

9.1% (n = 5)

14.3% (n = 35)

17.6% (n = 9)

Pneumonectomy

5.4% (n = 6)

10.9% (n = 6)

6.5% (n = 16)

7.8% (n = 4)

Sleeve

1.8% (n = 2)

0%

1.6% (n = 4)

0%

Chest wall

0.9% (n = 1)

1.8% (n = 1)

0%

0%

Analgesia

Epidural

40.5% (n = 45)

29.0% (n = 16)

37.1% (n = 91)

43.1% (n = 22)

0.217d

Intrathecal morphine

23.4% (n = 26)

36.4% (n = 20)

21.6% (n = 53)

21.6% (n = 11)

Morphine infusion

11.7% (n = 13)

10.9% (n = 6)

8.6% (n = 21)

5.9% (n = 3)

PCA

5.4% (n = 6)

7.3% (n = 4)

5.3% (n = 13)

5.9% (n = 3)

Paravertebral

18.9% (n = 21)

12.7% (n = 7)

26.5% (n = 65)

23.5% (n = 12)

Other

0%

3.6% (n = 2)

0.8% (n = 2)

0%

  1. BMI body mass index, FEV 1 forced expiratory volume in one second, COPD chronic obstructive pulmonary disease, ASA American Society of Anaethesiologists, VATS Video-assisted thoracoscopic surgery, PCA patient controlled analgesia.a ANOVA with Bonferroni post-hoc analysis;b Kruskal-Wallis test with Dunn Bonferroni post-hoc multiple comparison test;c Chi-sqaure test with Bonferroni post-hoc analysis;d Fisher’s Exact test with Bonferroni post-hoc analysis. When overall p-value is less than 0.05; each subscript letter(e-g) denotes a subset of smoking category whose column proportion does not differ significantly from each other (Bonferroni post-hoc multiple comparison test)